000 01872cam a2200373 4500500
005 20250121110751.0
041 _afre
042 _adc
100 1 0 _aRevol, Aurélie
_eauthor
245 0 0 _aMedical cannabis for elderly people with dementia: family caregivers’ enthusiasm
260 _c2019.
500 _a10
520 _aAt the end of 2017, at a Geneva nursing home where most of the residents are senior citizens with severe cognitive disorders, a pilot study was initiated where twelve residents were prescribed medical cannabis. Beyond the clinical effects of the pilot study, the sociological component of the study presented herein aims to understand how family carers perceive this new treatment. Families, who face suffering associated with companionship of the patients, are supportive of the treatment in the hope that it will improve the patients’ well-being. The positive expectations of therapeutic cannabis treatment are based on the families’ familiarity with the product, the fact that it offers a natural alternative to synthetic drugs, as well as the medical supervision of the treatment and the families trust in the institution where it is administered.
690 _afamily caregivers
690 _aalternative
690 _acomfort
690 _adrug
690 _aexpectations
690 _ainstitution
690 _aelderly people
690 _adementia
690 _amedical cannabis
690 _afamily caregivers
690 _aalternative
690 _acomfort
690 _adrug
690 _aexpectations
690 _ainstitution
690 _aelderly people
690 _adementia
690 _amedical cannabis
786 0 _nPsychotropes | 25 | 2 | 2019-11-29 | p. 129-149 | 1245-2092
856 4 1 _uhttps://shs.cairn.info/journal-psychotropes-2019-2-page-129?lang=en&redirect-ssocas=7080
999 _c538127
_d538127